Douglas Scherr, MD
Urology · New York, NYNPI 1114014206
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (57.7%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 77.0% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2020 at $6,299 and has fallen 92.0% since, to $503 in 2025.
Across 45 payments — averaging $211.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$7K
- Astrazeneca UK Limited$1K
- Urogen Pharma, Inc.$261
- Ferring Pharmaceuticals Inc.$170
- Pfizer$167
- Telix Pharmaceuticals$166
- plus $357 from 6 others
Across 16 payments — averaging $4491.93 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Urogen Pharma, Inc.$59K
- Artivion, Inc.$13K
What the payments were for
- Consulting fees$1,07411%
- Travel & lodging$1,51016%
- Food & beverage$1,44415%
- Education$5,50058%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 12 | $7,334 |
| Astrazeneca UK Limited | 1 | $1,074 |
| Urogen Pharma, Inc. | 17 | $261 |
| Ferring Pharmaceuticals Inc. | 5 | $170 |
| Pfizer | 2 | $167 |
| Telix Pharmaceuticals | 1 | $166 |
| EDAP Technomed Inc | 1 | $121 |
| Astellas Pharma US Inc | 1 | $94 |
| Janssen Scientific Affairs, LLC | 1 | $45 |
| Johnson & Johnson | 1 | $34 |
| Coloplast | 1 | $32 |
| Immunitybio, Inc. | 2 | $30 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$5,759
- DA VINCI SP$1,500
- ILLUCCIX$331
- XTANDI$135
How this compares
$9,529 in reported general payments places this provider in the 80th percentile of 952 urology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciprofloxacin Hcl | 461 | $1,186 |
| Tamsulosin Hcl | 61 | $764 |
| Tadalafil | 13 | $751 |
| Finasteride | 27 | $571 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 50 | $172 |
| Furosemide | 12 | $35 |
Paid to pharmacies, not to this prescriber.
Other urology in New York
- Bilal ChughtaiNew York$658K
- Katie MurrayNew York$575K
- Neil BanderNew York$544K
- Robert ValenzuelaNew York$494K
- Kyrollis AttallaNew York$381K
- Benjamin BruckerNew York$364K
- Ketan BadaniNew York$285K
- Michael GrassoNew York$284K
- Mantu GuptaNew York$229K
- Robin SmithNew York$215K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.